MELA Sciences Inc. (Nasdaq: MELA) welcomed the addition of Category III codes
to report multispectral digital skin lesion analysis of atypical
cutaneous lesions. The stock price leaped $1.06 to $3.14.
MELA welcomes new Category III codes
March 11, 2015 at 05:30 AM EDT
